Fibroblast growth factor 21 (fgf21) gene therapy for central nervous system disorders
Described herein is a gene construct comprising a nucleotide sequence encoding a fibroblast growth factor 21 (FGF21), for use in the treatment and/or prevention of a central nervous system (CNS) disorder or disease, or a condition associated therewith.
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English Hebrew |
Published |
01.01.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Described herein is a gene construct comprising a nucleotide sequence encoding a fibroblast growth factor 21 (FGF21), for use in the treatment and/or prevention of a central nervous system (CNS) disorder or disease, or a condition associated therewith. |
---|---|
Bibliography: | Application Number: IL20220298532 |